000597 东北制药
已收盘 05-08 15:00:00
资讯
新帖
简况
东北制药(000597)3月31日股东户数6.06万户，较上期减少6.71%
证券之星 · 04-29
东北制药(000597)3月31日股东户数6.06万户，较上期减少6.71%
图解东北制药一季报：第一季度单季净利润同比减36.98%
证券之星 · 04-28
图解东北制药一季报：第一季度单季净利润同比减36.98%
东北制药收盘上涨1.48%，滚动市盈率19.18倍，总市值78.60亿元
金融界 · 04-21
东北制药收盘上涨1.48%，滚动市盈率19.18倍，总市值78.60亿元
每周股票复盘：东北制药（000597）股东增持151.75万股，股价上涨6.63%
证券之星 · 04-18
每周股票复盘：东北制药（000597）股东增持151.75万股，股价上涨6.63%
东北制药最新公告：孙公司东药集团沈阳施德药业有限公司获得左卡尼汀口服溶液药品注册证书
证券之星 · 04-16
东北制药最新公告：孙公司东药集团沈阳施德药业有限公司获得左卡尼汀口服溶液药品注册证书
东北制药(000597.SZ)：方大钢铁累计增持公司151.75万股
智通财经网 · 04-15
东北制药(000597.SZ)：方大钢铁累计增持公司151.75万股
东北制药法定代表人变更为周凯
金融界 · 02-23
东北制药法定代表人变更为周凯
东北制药（000597）2月19日主力资金净买入227.72万元
证券之星 · 02-19
东北制药（000597）2月19日主力资金净买入227.72万元
东北制药(000597.SZ)：依非韦伦获化学原料药上市申请批准通知书
智通财经 · 02-14
东北制药(000597.SZ)：依非韦伦获化学原料药上市申请批准通知书
东北制药最新公告：依非韦伦原料药上市申请获批准
证券之星 · 02-14
东北制药最新公告：依非韦伦原料药上市申请获批准
【企业动态】东北制药新增2件法院诉讼
证券之星 · 02-08
【企业动态】东北制药新增2件法院诉讼
【量价齐升榜前十：爱威科技连续6天放量上涨，累计涨幅9.93%】截至2月7日收盘，爱威科技量价齐升，连续6天放量上涨，累计涨幅9.93%。其余量价齐升的上涨个股还包括：凯众股份（放量上涨5天）、金桥信息（放量上涨5天）、安恒信息（放量上涨5天）、金发科技（放量上涨5天）、用友网络（放量上涨5天）、东北制药（放量上涨4天）、中国联通（放量上涨4天）、广汇能源（放量上涨4天）、白云山（放量上涨4天）。
金融界 · 02-07
【量价齐升榜前十：爱威科技连续6天放量上涨，累计涨幅9.93%】截至2月7日收盘，爱威科技量价齐升，连续6天放量上涨，累计涨幅9.93%。其余量价齐升的上涨个股还包括：凯众股份（放量上涨5天）、金桥信息（放量上涨5天）、安恒信息（放量上涨5天）、金发科技（放量上涨5天）、用友网络（放量上涨5天）、东北制药（放量上涨4天）、中国联通（放量上涨4天）、广汇能源（放量上涨4天）、白云山（放量上涨4天）。
【企业动态】东北制药新增2件法院诉讼
证券之星 · 02-05
【企业动态】东北制药新增2件法院诉讼
东北制药：公司保健食品“东北健宜氨糖软骨素钙胶囊”，具有增加骨密度功效
互动易 · 02-05
东北制药：公司保健食品“东北健宜氨糖软骨素钙胶囊”，具有增加骨密度功效
一周复盘 | 东北制药本周累计上涨0.20%，化学制药板块下跌0.04%
金融界 · 02-02
一周复盘 | 东北制药本周累计上涨0.20%，化学制药板块下跌0.04%
【企业动态】东北制药新增1件法院诉讼，案由为建设工程分包合同纠纷
证券之星 · 01-21
【企业动态】东北制药新增1件法院诉讼，案由为建设工程分包合同纠纷
东北制药：全力保产保供 冲刺“开门红”
证券 · 01-21
东北制药：全力保产保供 冲刺“开门红”
【企业动态】东北制药新增2件法院诉讼
证券之星 · 01-14
【企业动态】东北制药新增2件法院诉讼
加载更多
公司概况
公司名称：
东北制药集团股份有限公司
所属行业：
医药制造业
上市日期：
1996-05-23
主营业务：
东北制药集团股份有限公司的主营业务是化学制药、医药商业、医药工程、生物医药等板块。公司的主要产品是维生素类、抗感染类、生殖系统和性激素类、神经系统类、抗艾滋病类、消化道类、麻精及含麻系列类、其他普药类、体外（生物）诊断试剂类。公司是国内首家左卡尼汀药用原料获批企业，也是国内药用左卡尼汀主要生产商及东维力口服溶液国家标准起草单位，拥有注射液和口服溶液两种剂型。
发行价格：
6.68
{"stockData":{"symbol":"000597","market":"SZ","secType":"STK","nameCN":"东北制药","latestPrice":5.26,"timestamp":1746687819000,"preClose":5.27,"halted":0,"volume":11013217,"delay":0,"changeRate":-0.0019,"floatShares":1407000000,"shares":1429000000,"eps":0.2719,"marketStatus":"已收盘","change":-0.01,"latestTime":"05-08 15:00:00","open":5.25,"high":5.28,"low":5.23,"amount":57933300,"amplitude":0.0095,"askPrice":5.27,"askSize":1029,"bidPrice":5.26,"bidSize":1036,"shortable":0,"etf":0,"ttmEps":0.2719,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746754200000},"marketStatusCode":5,"adr":0,"adjPreClose":5.27,"symbolType":"stock","openAndCloseTimeList":[[1746667800000,1746675000000],[1746680400000,1746687600000]],"highLimit":5.8,"lowLimit":4.74,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1429103265,"isCdr":false,"pbRate":1.41,"roa":"--","peRate":19.345348,"roe":"0.68%","epsLYR":0.29,"committee":-0.090188,"marketValue":7517000000,"turnoverRate":0.0078,"status":1,"floatMarketCap":7398000000},"requestUrl":"/m/hq/s/000597","defaultTab":"news","newsList":[{"id":"2531209912","title":"东北制药(000597)3月31日股东户数6.06万户，较上期减少6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531209912","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531209912?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:38","pubTimestamp":1745919485,"startTime":"0","endTime":"0","summary":"证券之星消息，近日东北制药披露，截至2025年3月31日公司股东户数为6.06万户，较12月31日减少4358.0户，减幅为6.71%。在化学制药行业个股中，东北制药股东户数高于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.17万户。从股价来看，2024年12月31日至2025年3月31日，东北制药区间跌幅为4.17%，在此期间股东户数减少4358.0户，减幅为6.71%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900033713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000597","BK0191"],"gpt_icon":0},{"id":"2530792554","title":"图解东北制药一季报：第一季度单季净利润同比减36.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530792554","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530792554?lang=zh_cn&edition=full","pubTime":"2025-04-28 18:54","pubTimestamp":1745837688,"startTime":"0","endTime":"0","summary":"证券之星消息，东北制药2025年一季报显示，公司主营收入19.47亿元，同比上升0.36%；归母净利润3632.16万元，同比下降36.98%；扣非净利润1990.7万元，同比下降33.29%；负债率58.82%，投资收益135.09万元，财务费用-768.06万元，毛利率34.11%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042800029195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597"],"gpt_icon":0},{"id":"2529825514","title":"东北制药收盘上涨1.48%，滚动市盈率19.18倍，总市值78.60亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529825514","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529825514?lang=zh_cn&edition=full","pubTime":"2025-04-21 16:11","pubTimestamp":1745223085,"startTime":"0","endTime":"0","summary":"4月21日，东北制药今日收盘5.5元，上涨1.48%，滚动市盈率PE达到19.18倍，创12天以来新低，总市值78.60亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均46.65倍，行业中值27.64倍，东北制药排名第62位。资金流向方面，4月21日，东北制药主力资金净流出715.10万元，近5日总体呈流出状态，5日共流出3001.41万元。东北制药集团股份有限公司的主营业务是化学制药、医药商业、医药工程、生物医药等板块。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/21161149707227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2528131640","title":"每周股票复盘：东北制药（000597）股东增持151.75万股，股价上涨6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528131640","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528131640?lang=zh_cn&edition=full","pubTime":"2025-04-19 03:11","pubTimestamp":1745003483,"startTime":"0","endTime":"0","summary":"截至2025年4月18日收盘，东北制药报收于5.42元，较上周的5.25元上涨3.24%。本周，东北制药4月17日盘中最高价报5.61元。本周关注点股本股东变化：江西方大钢铁集团有限公司增持151.75万股，占总股本0.1062%股本股东变化股东江西方大钢铁集团有限公司于2025年4月9日至2025年4月15日间合计增持151.75万股，占公司目前总股本的0.1062%，变动期间该股股价上涨6.63%，截止4月15日收盘报5.47元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041900004724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2527290874","title":"东北制药最新公告：孙公司东药集团沈阳施德药业有限公司获得左卡尼汀口服溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2527290874","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527290874?lang=zh_cn&edition=full","pubTime":"2025-04-16 19:30","pubTimestamp":1744803041,"startTime":"0","endTime":"0","summary":"东北制药(000597.SZ)公告称，全资孙公司东药集团沈阳施德药业有限公司收到国家药品监督管理局核准签发的《药品注册证书》，药品名称为左卡尼汀口服溶液，规格为10ml:1g，有效期为24个月。该药品用于治疗原发性系统性卡尼汀缺乏症，也用于先天性代谢异常导致的继发性卡尼汀缺乏症的短期和长期治疗。此次获得药品注册证书有利于进一步丰富公司产品管线，提升市场竞争力，但药品生产、销售情况受市场环境变化等因素影响，存在不确定性。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041600031694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0191","BK0239"],"gpt_icon":0},{"id":"2527463434","title":"东北制药(000597.SZ)：方大钢铁累计增持公司151.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2527463434","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527463434?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:32","pubTimestamp":1744727520,"startTime":"0","endTime":"0","summary":"东北制药(000597.SZ)发布公告，2025年4月15日，公司收到控股股东一致行动人方大钢铁出具的《东北制药集团股份有限公司详式权益变动报告书》《关于增持上市公司股份进展的告知函》。方大钢铁于2025年4月9日-2025年4月15日通过深圳证券交易所以集中竞价交易方式合计增持公司股份151.75万股，占公司总股本比例的0.106%。本次增持后，公司控股股东及其一致行动人合计持有公司股份7.86亿股，占公司总股本比例的55.00%。本次增持计划尚未实施完毕，方大钢铁将继续实施增持计划。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-15/doc-inethkct5249524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000597","BK0239","BK0191"],"gpt_icon":0},{"id":"2513978251","title":"东北制药法定代表人变更为周凯","url":"https://stock-news.laohu8.com/highlight/detail?id=2513978251","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513978251?lang=zh_cn&edition=full","pubTime":"2025-02-23 12:35","pubTimestamp":1740285349,"startTime":"0","endTime":"0","summary":"近日，天眼查APP显示，东北制药集团股份有限公司（简称“东北制药”）法定代表人发生变更，从郭建民变为周凯。资料显示，东北制药集团股份有限公司法定代表人为周凯，成立于1993年，位于沈阳市，是一家以从事医药制造业为主的企业。企业注册资本142910.3265万人民币，实缴资本142910.3265万人民币。通过天眼查大数据分析，东北制药集团股份有限公司共对外投资了22家企业，参与招投标项目3543次，知识产权方面有商标信息215条，专利信息144条，此外企业还拥有行政许可405个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/23123548331814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2512122146","title":"东北制药（000597）2月19日主力资金净买入227.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512122146","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512122146?lang=zh_cn&edition=full","pubTime":"2025-02-19 15:30","pubTimestamp":1739950200,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年2月19日收盘，东北制药报收于5.09元，下跌0.39%，换手率0.98%，成交量13.76万手，成交额6996.21万元。2月19日的资金流向数据方面，主力资金净流入227.72万元，占总成交额3.25%，游资资金净流出131.39万元，占总成交额1.88%，散户资金净流出96.33万元，占总成交额1.38%。东北制药主营业务：覆盖化学制药、医药商业、医药工程、生物医药等板块。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021900021035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2511666580","title":"东北制药(000597.SZ)：依非韦伦获化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2511666580","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511666580?lang=zh_cn&edition=full","pubTime":"2025-02-14 18:43","pubTimestamp":1739529812,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东北制药(000597.SZ)公告，近日，公司收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》，化学原料药名称为依非韦伦，是治疗人免疫缺陷病毒感染的关键药物，是人免疫缺陷病毒-1型(HIV-1)的选择性非核苷反转录酶抑制剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000597","BK0191","BK0239"],"gpt_icon":0},{"id":"2511665317","title":"东北制药最新公告：依非韦伦原料药上市申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2511665317","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511665317?lang=zh_cn&edition=full","pubTime":"2025-02-14 18:40","pubTimestamp":1739529624,"startTime":"0","endTime":"0","summary":"东北制药公告称，公司收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》，批准依非韦伦原料药上市。依非韦伦是治疗人免疫缺陷病毒感染的关键药物，适用于与其他抗病毒药物联合治疗HIV-1感染的成人、青少年及儿童。该原料药上市申请获得批准，表明公司产品的生产工艺稳定性、质量可控性符合中国药品相关技术要求，有利于进一步丰富公司产品管线，提升公司的市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021400033694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0191","BK0239"],"gpt_icon":0},{"id":"2510061699","title":"【企业动态】东北制药新增2件法院诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2510061699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510061699?lang=zh_cn&edition=full","pubTime":"2025-02-09 05:56","pubTimestamp":1739051771,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，2月8日东北制药（000597）新增2件法院诉讼如下：案号：（2025）辽0191民初1482号法院：沈阳经济技术开发区人民法院案由：买卖合同纠纷原告：辽宁实发洁净科技有限公司被告：东北制药集团股份有限公司案件类型：民事立案日期：2025年2月8日案号：（2025）辽0191执763号法院：沈阳经济技术开发区人民法院案由：买卖合同纠纷案件执行申请执行人：基伊埃工程","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025020900000154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0239","BK0191"],"gpt_icon":0},{"id":"2509791787","title":"【量价齐升榜前十：爱威科技连续6天放量上涨，累计涨幅9.93%】截至2月7日收盘，爱威科技量价齐升，连续6天放量上涨，累计涨幅9.93%。其余量价齐升的上涨个股还包括：凯众股份（放量上涨5天）、金桥信息（放量上涨5天）、安恒信息（放量上涨5天）、金发科技（放量上涨5天）、用友网络（放量上涨5天）、东北制药（放量上涨4天）、中国联通（放量上涨4天）、广汇能源（放量上涨4天）、白云山（放量上涨4天）。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509791787","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509791787?lang=zh_cn&edition=full","pubTime":"2025-02-07 16:45","pubTimestamp":1738917912,"startTime":"0","endTime":"0","summary":"截至2月7日收盘，爱威科技量价齐升，连续6天放量上涨，累计涨幅9.93%。其余量价齐升的上涨个股还包括：凯众股份（放量上涨5天）、金桥信息（放量上涨5天）、安恒信息（放量上涨5天）、金发科技（放量上涨5天）、用友网络（放量上涨5天）、东北制药（放量上涨4天）、中国联通（放量上涨4天）、广汇能源（放量上涨4天）、白云山（放量上涨4天）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/07164548014362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688023","BK0231","BK1191","600143","BK0174","BK0239","BK0038","BK0220","BK1589","600332","BK0196","00874","SG9999002463.SGD","BK0164","BK0070","603037","BK0251","BK1506","600050","603918","BK0096","BK0274","00762","BK1536","000597","BK1606","BK0010","BK0261","LU1781817850.SGD","BK0019","688067","BK1515","LU1969619763.USD","CHU","LU2148510915.USD","600256","BK0012","BK0183","BK0142","BK0264","BK1197","BK0029","BK1133","BK0119","BK0175","LU1064131003.USD","BK0006","BK0028","BK0082","600588"],"gpt_icon":0},{"id":"2509252601","title":"【企业动态】东北制药新增2件法院诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2509252601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509252601?lang=zh_cn&edition=full","pubTime":"2025-02-06 05:57","pubTimestamp":1738792630,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，2月5日东北制药（000597）新增2件法院诉讼如下：案号：（2025）辽0191民初1334号法院：沈阳经济技术开发区人民法院案由：建设工程分包合同纠纷原告：史某某被告：马某某、沈阳东北制药装备制造安装有限公司、东北制药集团股份有限公司案件类型：民事立案日期：2025年2月5日案号：（2025）辽0191民初1316号法院：沈阳经济技术开发区人民法院案由：建设工","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025020600002580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2509426085","title":"东北制药：公司保健食品“东北健宜氨糖软骨素钙胶囊”，具有增加骨密度功效","url":"https://stock-news.laohu8.com/highlight/detail?id=2509426085","media":"互动易","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509426085?lang=zh_cn&edition=full","pubTime":"2025-02-05 11:33","pubTimestamp":1738726380,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 有投资者向东北制药提问， 本人关注公司，请问贵公司应该不涉及人体骨骼相关产品吧？公司回答表示，尊敬的投资者您好，公司保健食品“东北健宜氨糖软骨素钙胶囊”，具有增加骨密度功效。感谢您对公司的关注。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-02-05/doc-ineikxsh2852205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000597","BK0239","BK0191"],"gpt_icon":0},{"id":"2508902334","title":"一周复盘 | 东北制药本周累计上涨0.20%，化学制药板块下跌0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508902334","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508902334?lang=zh_cn&edition=full","pubTime":"2025-02-02 11:21","pubTimestamp":1738466496,"startTime":"0","endTime":"0","summary":"【行情表现】1月27日至1月27日本周深证成指下跌1.33%，化学制药板块下跌0.04%。东北制药本周累计上涨0.20%，周总成交额6673.82万元，截至本周收盘，东北制药股价为4.99元。【同行业公司股价表现——化学制药】代码名称最新价周涨跌幅10日涨跌幅月涨跌幅600276恒瑞医药44.65元0.02%4.3%-2.72%600789鲁抗医药8.90元-0.45%0.0%-6.81%002001新和成22.51元0.09%4.45%3.40%002422科伦药业28.13元-0.04%0.97%-6.01%688166博瑞医药30.92元4.07%7.1%2.38%","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/02112147931520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","01477","BK1191","BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2505780001","title":"【企业动态】东北制药新增1件法院诉讼，案由为建设工程分包合同纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2505780001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505780001?lang=zh_cn&edition=full","pubTime":"2025-01-22 05:55","pubTimestamp":1737496512,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，1月21日东北制药（000597）新增1件法院诉讼如下：案号：（2025）辽0191民初1072号法院：沈阳经济技术开发区人民法院案由：建设工程分包合同纠纷原告：安某某被告：沈阳东北制药装备制造安装有限公司、东北制药集团股份有限公司案件类型：民事立案日期：2025年1月21日数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012200004833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2505783817","title":"东北制药：全力保产保供 冲刺“开门红”","url":"https://stock-news.laohu8.com/highlight/detail?id=2505783817","media":"证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505783817?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:38","pubTimestamp":1737481080,"startTime":"0","endTime":"0","summary":"近日，笔者走进东北制药，感受到企业生产经营正在释放浓浓暖意，感受到开年即起跑的满满活力。为保障国内市场供应和出口订单需求，东北制药各生产单位在开年首月便马力全开，抢时间、保供应。东北制药产品远销100多个国家和地区，离不开过硬的产品质量。技术创新赋能降本增效在全力冲刺“开门红”的过程中，东北制药不仅注重眼前的销售业绩和生产效率，更着眼于企业的长远发展和持续创新。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-01-22/doc-inefupap7542146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2503680898","title":"【企业动态】东北制药新增2件法院诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2503680898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503680898?lang=zh_cn&edition=full","pubTime":"2025-01-15 06:02","pubTimestamp":1736892157,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，1月14日东北制药（000597）新增2件法院诉讼如下：案号：（2025）辽0191民初772号法院：沈阳经济技术开发区人民法院案由：建设工程施工合同纠纷原告：辽宁华夏天通科技股份有限公司被告：东北制药集团股份有限公司案件类型：民事立案日期：2025年1月14日案号：（2025）辽0191民初767号法院：沈阳经济技术开发区人民法院案由：建设工程合同纠纷原告：沈阳","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011500005588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746735202121,"stockEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":0.0253},{"period":"3month","weight":0.0174},{"period":"6month","weight":-0.1054},{"period":"1year","weight":0.0665},{"period":"ytd","weight":-0.0019}],"compareEarnings":[{"period":"1week","weight":0.0223},{"period":"1month","weight":0.0656},{"period":"3month","weight":0.0146},{"period":"6month","weight":-0.0291},{"period":"1year","weight":0.0714},{"period":"ytd","weight":0.0001}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"东北制药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"60559人(较上一季度减少6.71%)","perCapita":"23225股","listingDate":"1996-05-23","address":"辽宁省沈阳市铁西区经济技术开发区昆明湖街","registeredCapital":"142910万元","survey":" 东北制药集团股份有限公司的主营业务是化学制药、医药商业、医药工程、生物医药等板块。公司的主要产品是维生素类、抗感染类、生殖系统和性激素类、神经系统类、抗艾滋病类、消化道类、麻精及含麻系列类、其他普药类、体外（生物）诊断试剂类。公司是国内首家左卡尼汀药用原料获批企业，也是国内药用左卡尼汀主要生产商及东维力口服溶液国家标准起草单位，拥有注射液和口服溶液两种剂型。","listedPrice":6.68},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东北制药(000597)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东北制药(000597)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东北制药,000597,东北制药股票,东北制药股票老虎,东北制药股票老虎国际,东北制药行情,东北制药股票行情,东北制药股价,东北制药股市,东北制药股票价格,东北制药股票交易,东北制药股票购买,东北制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东北制药(000597)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东北制药(000597)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}